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Article
I n t r o d u c t i o n
Transmissible spongiform encephalopathies (TSEs) are a group of 
fatal, degenerative neurological diseases, including scrapie in sheep 
and goats; chronic wasting disease (CWD) in deer and elk; bovine 
spongiform encephalopathy (BSE); and a heterogeneous group of 
iatrogenic, sporadic, familial, and transmitted diseases in humans 
(1). In Canada, scrapie was first diagnosed in a sheep imported from 
Britain in 1938 and occurs at a very low level (2). Chronic wasting 
disease was first diagnosed in Canada in 1996 (2). 
Evaluation of Western blotting methods using samples with or without 
sodium phosphotungstic acid precipitation for diagnosis of scrapie and 
chronic wasting disease
Hongsheng Huang, Jasmine Rendulich, Dan Stevenson, Katherine O’Rourke, Aru Balachandran
A b s t r a c t
The purpose of this study was to enhance the sensitivity of the Western blot (WB) test for use as an alternative and confirmatory 
method for the diagnosis of scrapie and chronic wasting disease (CWD) in Canada by comparing 2 sample preparation proce-
dures: an abnormal prion protein (PrPSc) concentration procedure using sodium phosphotungstic acid (PTA) precipitation and 
a procedure using crude sample without precipitation. A total of 100 cerebrum samples (52 sheep and 48 elk), including 
66 negative (31 sheep, 35 elk) and 34 positive (21 scrapie and 13 CWD positive) samples diagnosed by using immunohistochem-
istry (IHC) on retropharyngeal lymph node (RPLN) and medulla oblongata at obex, were tested by using WB with the 2 sample 
preparation procedures. The WB using non-PTA enriched sample (crude extract) detected, on average, only 71.7% (9 of 15, 60.0% 
for scrapie, 5 of 6, 83.3% for CWD) of the samples that tested positive by using WB with PTA enriched samples. No case was 
positive by WB using crude extract but negative by WB using PTA enriched sample. No false positive was found. Serial dilution 
of PTA precipitated samples demonstrated that the technique increases the detection limit approximately 100 fold. Additionally, 
the comparison of the WB and IHC on cerebrum from all the positive cases demonstrated that WB following PTA precipitation 
and IHC had 100% agreement by detecting 6 positive for CWD on cerebrum; while IHC detected scrapie in only 14 out of 
15 positive cerebrum samples by using WB following PTA precipitation. Phosphotungstic acid precipitation is therefore a useful 
adjunct to WB analysis of scrapie and CWD and tissues.
Résumé
Afin d’augmenter la sensibilité de l’épreuve d’immunobuvardage (WB) pour utilisation comme méthode alternative et de confirmation pour 
le diagnostic de la tremblante et de la maladie débilitante chronique (CWD) au Canada, deux méthodes de préparation des échantillons pour 
l’épreuve de détection par WB, la concentration de protéine prion anormale (PrPSc) par précipitation à l’aide de phosphotungstate de sodium 
(PTA) et une méthode utilisant l’échantillon brut sans précipitation ont été comparées. Un total de 100 échantillons de cerveau (52 moutons 
et 48 cerfs), incluant 66 négatifs (31 moutons et 35 cerfs) et 34 positifs (21 moutons avec de la tremblante et 13 cerfs positifs pour le CWD), 
diagnostiqués par examen immunohistochimique (IHC) des ganglions rétro-pharyngiens (RPLN) et de la moëlle allongée à l’obex, ont été 
testés à l’aide de la méthode WB en utilisant les deux modes de préparation des échantillons. L’épreuve WB effectuée sur les échantillons 
préparés sans précipitation a permis de détecter, en moyenne, seulement 71,7 % (9 sur 15, 60,0 % pour la tremblante; 5 sur 6, 83,3 % pour 
CWD) des échantillons qui se sont avérés positifs par WB lorsque la méthode de préparation PTA a été utilisée. En aucune circonstance un 
échantillon positif par WB préparé sans précipitation s’est-il avéré négatif lorsque préparé par la méthode PTA. Aucun résultat faux positif 
ne fut trouvé. Des dilutions sériées des échantillons précipités avec PTA ont permis de démontrer que cette méthode de préparation augmen-
tait la limite de détection par un facteur de 100. De plus, lors de la comparaison de tous les résultats positifs par les méthodes WB et IHC, 
l’épreuve WB, suite à la préparation PTA, et la méthode IHC avaient 100 % de concordance pour détecter des échantillons de cerveau posi-
tifs pour CWD; alors que pour les cas de tremblante l’épreuve IHC ne détecta que 14 des 15 échantillons de cerveau démontrés positifs par 
WB suite à la préparation PTA. Ainsi, la précipitation avec PTA est un ajout utile pour l’analyse par WB d’échantillons provenant d’animaux 
suspectés de tremblante et de CWD.
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The TSEs are characterized by vacuolation and loss of neurons in 
the central nervous system, and by the accumulation of the disease 
isoform (abnormal prion protein or PrPSc) of host encoded cellular 
(normal) prion protein (PrPC) (1). Although the exact nature of the 
causative agent for TSE is still controversial, PrPSc is associated with 
the pathogenesis of the TSEs and copurifies with infectivity (1). It is 
generally believed that PrPSc is at least a major component of the 
causative agent for TSEs (1) and PrPSc is a reliable marker for TSE 
diagnosis. To date, there is no single completely satisfactory diag-
nostic method for TSE. The diagnosis of TSE has been mainly based 
on histopathological findings combined with the demonstration of 
the PrPSc by immunohistochemistry (IHC), Western blotting (WB), 
or scrapie-associated fibrils (SAF) by electron microscopy (EM) (3,4). 
More recently, several immunoassays have been validated as rapid 
screening tests for TSE (5–7). Of the methods mentioned above, 
histopathology and IHC examinations are routinely used and con-
sidered “gold” standard methods. Histopathological lesions can 
only be identified in the late stages of the incubation period (8), 
although the disease can be diagnosed in early stages through the 
detection of PrPSc in nervous tissue (3,4,6,7). The PrPSc are not dis-
tributed uniformly throughout the brains of infected animals. The 
medulla, at the level of the obex, is the most reliable site for testing 
in early cases of scrapie, BSE, and CWD (4,7,9–16). Therefore, immu-
nodetection of PrPSc by IHC or WB in this region of the brain is 
considered optimal for early detection of the disease, before the onset 
of brain lesions or clinical disease (4,7,9–12,15). Further, immunode-
tection of PrPSc by WB and IHC and detection of SAF by EM are not 
affected by autolysis (17–21), and thus are useful tools for confirm-
ing a diagnosis when histopathological examination is inconclusive 
as a result of post-mortem autolysis or poor preservation. The WB 
method can demonstrate a typical pattern of 3 bands including 
diglycosylated (high molecular mass), monoglycosylated (medium 
molecular mass), and unglycosylated (the lowest molecular mass) 
components in a certain molecular weight range. Thus WB is a valu-
able confirmatory tool for tests such as immunoassays, which do not 
show characteristic features of PrPSc. Validation studies in Europe 
indicate that WB is useful as a diagnostic tool for clinically suspected 
BSE and scrapie cases, as well as for rapid surveillance or screening 
to detect subclinically infected animals (7,15,16).
The detection sensitivity of WB tests in published studies varies 
due to differences in tissue preparation methods, animal species, 
and tissue types used (12,16,22,23). In addition, WB analysis is lim-
ited by the quantity of sample that can be loaded onto gels for 
electrophoresis. The sensitivity of the WB test can be improved by 
pretreatments that concentrate PrPSc. An ultracentrifugation proce-
dure has been commonly used and recommended by the interna-
tional animal health organization, Office International Des Epizooties 
(OIE) (3). More recently, sodium phosphotungstic acid (PTA) has 
been shown to specifically precipitate PrPSc molecules (24). The PTA 
precipitation of PrPSc from variant Creutzfeldt-Jakob disease (vCJD) 
affected brains increases the sensitivity of WB analysis (23). However, 
PTA precipitation procedure followed by WB has not been validated 
for diagnosis of CWD and scrapie. The objective of the present study 
was to compare the sensitivity of PTA-enriched samples and non-
enriched samples through WB analysis in order to diagnose CWD 
and scrapie.
M a t e r i a l s  a n d  m e t h o d s
Samples
One hundred cases, including 52 from sheep (21 scrapie positive, 
31 negative) and 48 from elk (13 CWD positive and 35 negative) from 
different farms in Canada and diagnosed between 1999 and 2003, 
were selected at random from archived tissues for analysis in this 
study (Table I). These samples were submitted for diagnosis of 
scrapie and CWD as part of the TSE control program in Canada or 
collected from a research project involving natural scrapie infection. 
All of the above cases had formalin-fixed medulla and retropharyn-
geal lymph node (RPLN) samples for diagnosis of scrapie and CWD 
by IHC as described for sheep (25) and elk (12). In the IHC tests, 
monoclonal antibodies (Mabs) F89/160.1.5 (26) and F99/97.6.1 (11) 
(provided by Dr. K. O’Rourke, ADRU, ARS, USDA, Pullman, 
Washington State, USA) were pooled (3 g/mL each final concentra-
tion) to test for scrapie and F99/97.6.1 alone (3 g/mL final concen-
tration) was used to test for CWD. All of the positive cases used in 
this study were found positive by IHC on RPLN, and some were 
also positive on the medulla oblongata at the obex and even fewer 
tested positive on cerebrum (Table I). For the positive cases used in 
this study, no case tested positive in brain but negative on RPLN by 
IHC. Due to availability of the samples, only samples of cerebrum 
were used in the current study.
In this study, cases that were positive for scrapie or CWD were 
defined based on positive results on RPLN by IHC. For the WB 
assays in this study, frozen cerebrum samples from 31 sheep and 
35 elk that tested negative by IHC on formalin-fixed obex and RPLN 
were used as controls for WB (Table I). Among the above 66 negative 
cases, cerebrum samples of 14 negative cases (9 sheep and 5 elk, 
respectively), collected from the region adjacent to that used for WB, 
were also tested by IHC for negative controls. The WB and IHC tests 
Table I. Immunohistochemical (IHC) results for retropharyngeal lymph node (RPLN), obex, 
and cerebrum samples from elk and sheep exposed to chronic wasting disease (CWD) 
and scrapie under farm conditions
  Number of 
 Total number IHC negative  Number of IHC positive
Species tested (RPLN and medulla) RPLN Medulla Cerebrum
Sheep 52a 31 21 20 14
Elk 48a 35 13 13  6
a Number of animals tested
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were conducted for all the positive cases using the adjacent region 
of cerebrum samples, namely, one section of formalin-fixed for IHC 
and one portion frozen for WB. All the frozen tissues were stored at 
80°C for long term storage or at 20°C for immediate use.
Tissue preparation for WB
Tissues were prepared as described (27) with minor modifications. 
Briefly, 0.2 to 0.25 g of tissues were homogenized with disposable 
probes or with a cell disrupter (FastPrep Cell Disrupter; Qbiogene 
SA, Carlsbad, California, USA), as described below. One milliliter 
of lysis buffer containing 0.5% Nodinet P-40 (B56009-70; EM Science, 
Darmstdt, Germany) and 0.5% sodium deoxycholate (102906; ICN 
Biomedicals, Aurora, Ohio, USA, or B43035-24; EM Science), in 
10 mM Tris buffer, pH 7.5, was added to obtain a homogenate con-
taining approximately 20% (w/v) tissue. Approximately 1 gram of 
Zirconia in the form of 1 mm (in diameter) microbeads (BioSpec 
Products, Bartlesville, Oklahoma, USA) was added and vortexed for 
1 min or homogenized using the cell disrupter (FastPrep Cell 
Disrupter) at a speed setting of 6.5 for 45 s. The homogenate was 
incubated at room temperature for 30 min, and either processed 
immediately or stored at 20°C. 
For PTA enriched sample preparation (12,23), 0.6 mL of the above 
lysed 20% homogenate was treated with an equal volume of 4% 
sarkosyl solution, consisting of 4% N-lauroyl sodium sarcosinate 
(L-9150; Sigma Chemical Company, Oakville, Ontario) in phosphate 
buffered saline solution (PBSS), pH 7.4, at 37°C for 10 min, followed 
by DNAse I (100 g/mL) (D-5025; Sigma Chemical Company) treat-
ment at 37°C for 30 min. Following centrifugation at 1538  g 
(4000 rpm) for 10 min, 1 mL of the supernatant was incubated with 
proteinase K (PK) (P-2308; Sigma Chemical Company) at a final 
concentration of 50 g/mL at 50°C for 40 min to destroy PrPC. The 
PrPC is soluble and susceptible to PK digestion, whereas PrPSc is 
resistant thus distinguishing between normal and disease specific 
isoforms of PrP. In addition, there are no antibodies currently avail-
able that can differentiate PrPC from PrPSc. After PK digestion, 
Pefablock SC (1 429 868; Roche Diagnostics, Laval, Quebec) (2 mM 
final concentration) was added to stop PK activity. The supernatant 
was then incubated with 80 L of PTA (P-6395; Sigma Chemical 
Company) (4%, w/v, in 170 mM MgCl, pH 7.4) at a final concentra-
tion of 0.3%, followed by centrifugation at 16 249  g (13 000 rpm) 
for 30 min. The pellet was resuspended in 12 L water for testing or 
stored at 20°C if not tested immediately.
For crude extract (non-PTA enriched) preparation, the homogenate 
was diluted 1:1 with lysis buffer to produce a 10% homogenate. For 
each sample, 12 L of this homogenate was treated with PK at a final 
concentration of 50 g/mL at 50°C for 40 min. The PK activity 
was stopped by Pefablock SC (2 mM final concentration) (27). A 
2nd aliquot, 6 L of the above 10% homogenate, was further diluted 
with an equal volume of sterile water and used as PK negative 
control.
Gel electrophoresis and Western blotting
The WB analysis was based on the method described by Tuo et al 
(27) with some modifications. Briefly, each sample (12 L) was mixed 
with NuPAGE sample buffer (15 L) and reducing agent (3 L) 
(Invitrogen, Burlington, Ontario), then heated to 100°C for 10 min 
followed by centrifugation at 16 249  g (13 000 rpm) for 5 min. 
Twelve microliters of supernatant was electrophoresed (50 min, 
200 volts) onto NuPAGE pre-cast 12% Bis-Tris buffered sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
(Invitrogen) using MOPS running buffer (Invitrogen). Gels were then 
electroblotted using semi-dry transfer apparatus (Bio-Rad, 
Mississauga, Ontario) in transfer buffer containing 0.025 M Tris base, 
0.15 M glycine, and 10% (v/v) methanol for 1.5 h at 15 volts onto 
polyvinylidene fluoride (PVDF) membrane (Bio-Rad). The PVDF 
membranes were fixed for 15 s in methanol, followed by either 
complete air drying for 15 min or immediate incubation in blocking 
buffer as below. The PVDF membrane was pre-wetted in methanol 
and then rinsed in water and immediately incubated in blocking 
buffer (5% non-fat milk in 20 mM Tris-HCL, pH 7.5, 137 mM NaCl, 
0.2% Tween-20) for either 1 h at room temperature or overnight at 
4°C. The membrane was incubated for 1 h at room temperature with 
3.5 g per mL of monoclonal antibody F99/97.6.1 (either provided 
by Dr. K. O’Rourke, or purchased from VMRD, Pullman, Washington 
State, USA), which recognizes a conserved epitope on the ruminant 
PrPC and PrPSc molecules (25) in WB and IHC assay. After washing 
3 times (5 min for each) with TBS-T (20 mM Tris-HCL, pH 7.5, 
137 mM NaCl, 0.2% Tween-20), the membrane was incubated with 
goat anti-mouse polyclonal serum conjugated with horseradish 
peroxidase (170-6510; Bio-Rad) diluted 1:3000 in blocking buffer. 
After washing 5 times (5 min per wash) with TBS-T, the membrane 
was incubated with chemiluminescent substrate, ECL Plus (RPN2132; 
Amersham Biosciences, Baie d’Urfé, Québec), for 5 min, and chemi-
luminescent signals were visualized by exposing the membrane to 
x-ray film (Kodak x-ray film; InterScience, Mississauga, Ontario). 
The samples were declared positive if the characteristic banding 
patterns of PK-resistant core of PrPSc were present.
Comparison of PrPSc enrichment by PTA versus 
non-enrichment
To determine the degree of enrichment achieved with PTA 
precipitation, dilutions (30%, 10%, and 1% v/v) of 2 PTA- 
precipitated samples in NuPAGE sample buffer were prepared 
prior to gel electrophoresis and analyzed by WB. The WB pro-
file seen with the PTA enriched samples was frequently dense 
and without clearly defined bands, presumably due to excess 
proteins. To confirm the presence of PrPSc, 5 such samples were 
selected, serially diluted, and then tested to determine if the typi-
cal band pattern, namely 3 bands (diglycosylated, monoglyco-
sylated, and unglycosylated bands) between 20 to 30 kDa, was 
obtained.
Comparison of WB method using PTA enriched 
samples or crude extracts with IHC
As mentioned above, scrapie or CWD positive cases were deter-
mined based on the positive results on RPLN by IHC examinations 
for this study. All of the positive cases used in this study were 
positive by IHC on RPLN, and some were positive on the medulla 
oblongata at the obex with fewer positive numbers on cerebrum 
(Table I). Based on the availability of the tissues, the WB assay results 
were compared to IHC results for cerebrum samples of 21 scrapie 
positive and 13 CWD positive animals only. Additional cerebrum 
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samples from 9 scrapie-negative and 5 CWD-negative animals were 
tested by both WB and IHC as controls.
R e s u l t s
Distribution of PrPSc in RPLN, medulla at the level 
of the obex, and cerebrum of sheep and elk, as 
detected by IHC
Samples from 100 animals (52 sheep and 48 elk) were randomly 
selected from archived tissue collected over the course of Canadian 
scrapie and CWD control programs and research projects with 
natural scrapie infection. Scrapie and CWD were diagnosed through 
examination of the RPLN for deposits of PrPSc detectable by IHC. 
Samples of medulla at the level of the obex were also analyzed from 
each animal (Table I). Thirty-one sheep and 35 elk that had no evi-
dence of PrPSc in any tissue were considered PrPSc negative for this 
study. However, the animals were from farms with at least 1 positive 
TSE case and may represent animals in the early stages of disease, 
when PrPSc is undetectable with the current testing methods. Of the 
21 scrapie positive sheep with IHC-positive RPLN, 20 had PrPSc in 
the medulla and 14 had PrPSc in the cerebrum by IHC (Table I). 
Thirteen elk with IHC-positive RPLN also had positive medulla 
samples; of these elk, only 6 had positive immunostaining in the 
cerebrum.
Phosphotungstic acid enrichment of PrPSc
To compare the sensitivity of the WB using the PTA enrichment 
procedure with that using the non-enrichment procedure, 2 samples 
that were WB negative using the crude homogenate but positive 
using PTA enrichment were prepared by PTA precipitation and 
examined as the original PTA sample (100%) and diluted to 30%, 
10%, and 1% of the starting volume before analysis. Strong signals 
were observed with the 30% and 10% dilutions and a weak signal 
in the 1% sample (Figure 1). Starting wet weight equivalents for these 
samples were 0.6 mg per lane in the crude homogenate, 60 mg in the 
100% PTA precipitate, 20 mg in the 30% dilution, 6 mg in the 10% 
dilution, and 0.6 mg in the 1% dilution. The sample volume loaded 
per lane on the gel for the PTA procedure was equivalent to approx-
imately 60 mg wet brain tissue and 0.6 mg for non-enrichment 
procedure. Namely, the PTA procedure uses 100-fold more sample 
than that of the non-enrichment procedure. Therefore, it is estimated 
that most of the PrPSc could be precipitated by PTA.
Comparison of WB using PTA enriched samples 
with those of crude extracts
Of the 15 samples of sheep cerebrum that tested positive with WB 
using PTA enrichment procedure, 9 (60.0%) were positive by WB 
using crude homogenate (Table II). Representative data from 
WB analysis of the sheep samples are shown in Figure 2. Samples 30 
and 32 show the typical PrPSc banding pattern in crude homogenates 
(Figure 2, lanes 8 and 14) with a large increase in the signal following 
PTA precipitation (Figure 2, lanes 9 and 15). Sample 31 showed a 
weak signal with the crude homogenate, which was improved by 
Table II. Comparison of immunohistochemistry (IHC) and Western blot (WB) assay with 
and without phosphotungstic acid (PTA)-enrichment for cerebrum samples from chronic 
wasting disease (CWD) positive elk and scrapie positive sheep
 Total number  WB positive using WB positive
Species compareda IHC positiveb crude homogenatec using PTAd
Sheep 21 14 9 15
Elk 13  6 5  6
a PrPSc detected by IHC on retropharyngeal lymph node (RPLN)
b PrPSc detected by IHC on formalin fixed cerebrum
c Number of samples with positive findings by WB using crude homogenates
d Number of samples with positive findings by WB following PTA precipitation
Figure 1. Effects of phosphotungstic acid (PTA) precipitation, dilution limit, 
using cerebral sample from a scrapie positive case. Lane 1, crude extract 
(PrPSc not detected); 2, original (100%) PTA precipitated sample; 3 to 5, 
serially (30%, 10%, and 1%, respectively) diluted from the original PTA 
enriched sample on lane 2.
Figure 2. Detection of scrapie PrPSc by Western blot (WB) of crude homog-
enates and phosphotungstic acid (PTA) precipitated samples from sheep 
sample 19 (lanes 1 to 3), sample 1 (lanes 4 to 6), sample 32 (lanes 7 to 9), 
sample 31 (lanes 10 to 12), and sample 30 (lanes 13 to 15). Samples were 
incubated without proteinase K (PK) (lanes 1, 4, 7, 10, 13), with PK as a 
crude extract (lanes 2, 5, 8, 11, 14) or with PTA precipitation after PK diges-
tion (lanes 3, 6, 9, 12, 15). MW markers (arrows) 30 kDa and 20 kDa shown 
on left.
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PTA precipitation (Figure 2, lanes 11 and 12). Sample 19 and 
1 showed no signal with the crude homogenate (Figure 2, lanes 2 
and 5), although PrPSc was detectable in both samples following PTA 
precipitation (Figure 2, lanes 3 and 6). The PTA precipitation of 
samples with large amounts of PrPSc resulted in a signal without a 
clearly defined pattern of bands. Serial dilution of these samples 
resolved the bands and the typical pattern of PrPSc could be demon-
strated. Figure 3 shows 1 of 5 such diluted samples.
Of the 6 elk cerebrum samples that were positive for CWD by IHC 
on paired fixed tissue, 5 were positive by using the crude homoge-
nate without PTA precipitation (Table II, Figure 4). An additional 
sample was positive following PTA precipitation (Figure 4, lane 5), 
although the crude homogenate was negative (Figure 4, lane 6). No 
signal was observed from PK treated samples that were negative by 
IHC (Figure 4, lanes 2 and 3). Samples that were positive by using 
crude extracts (sample 10, lane 9) showed an increased signal fol-
lowing PTA precipitation (lane 10).
For all scrapie and CWD cases, there was no case that was positive 
by WB using crude extract but negative by WB using PTA enriched 
sample. Meanwhile, there was a positive correlation between the 
intensity of the PrPSc bands detected by non-enriched and PTA-
enriched positive samples; the more intense the bands detected by 
PTA-enriched sample, the more intense the bands by non-enriched 
method (Figures 2 and 4).
Comparison of the results of WB and IHC tests
The WB tests using both PTA enriched samples and crude extracts 
were 100% specific; all 66 TSE-negative samples (31 sheep and 
35 elk with no detectable PrPSc in RPLN and medulla at obex) were 
negative by WB using either procedure (Table II). In addition, 
14 negative samples (9 sheep and 5 elk), randomly selected from the 
cerebral region as controls, were negative by both IHC and WB. The 
sensitivity of WB using PTA enriched samples was 100% for CWD 
(6/6 samples). The WB using PTA enrichment procedure detected 
15 samples of cerebrum that were positive for scrapie, while IHC 
identified 14 samples of cerebrum that were positive for scrapie; 
namely, the WB following PTA precipitation identified one more 
positive scrapie case when compared with IHC on cerebrum. For 
this additional positive case, the brain stem was also positive by WB 
with and without PTA enrichment and the obex was positive by IHC 
(not shown). This case also showed band patterns similar to other 
scrapie positive cases by WB (not shown). The sensitivity was lower 
(64.3%, 9 of 14 for scrapie and 83.3%, 5 of 6 samples for CWD) for 
non-PTA procedure when compared with IHC on cerebrum (Table II).
D i s c u s s i o n
Phosphotungstic acid enrichment has been applied to brain, ton-
sil, and muscle tissues in either WB or immunoassays in humans, 
mice, sheep, deer, and elk (12,23,24,28–31). The objective of this study 
was to compare the performance of 2 tissue preparation methods, 
crude and PTA enrichment, for WB detection of PrPSc in brain tissue 
from elk and sheep exposed to a TSE under field conditions. 
Phosphotungstic acid precipitation increased the sensitivity of the 
WB analysis for sheep and elk PrPSc approximately 100-fold, a find-
ing similar to that reported for detection of human PrPSc from cases 
of vCJD (23). The WB following PK digestion and PTA precipitation 
of cerebrum tissue detected all of the positive cerebral samples of 
the same animals as identified by IHC for both scrapie and CWD 
cases. In addition, WB following PK digestion and PTA precipitation 
detected one more scrapie positive cerebrum, which was negative 
by IHC. No unusual findings, such as PrPSc distribution in various 
brain sites or band patterns by WB, were observed in this case. The 
reason for identification of this additional positive case, from a 
sample of cerebrum by WB using PTA enrichment, is not clear. It 
could be due to the higher sensitivity of this procedure than IHC. 
Another reason could be the uneven distribution of the PrPSc in the 
tissues (7,12,20). The WB, without PTA precipitation, showed a lower 
sensitivity, 64.3% for sheep and 83.3% for elk, when compared with 
IHC of cerebrum samples. The only tissue for which both frozen and 
fixed samples were available for this comparison was cerebrum, a 
region of the brain that is a less sensitive indicator of disease than 
the medulla at the obex in sheep, cattle, deer, and elk, or the lymph 
node in sheep, deer, and elk. Availability of paired tissues from 
animals sampled in regulatory programs remains an obstacle to large 
scale studies evaluating test methodologies based on fixed versus 
frozen tissues.
The results from the current study demonstrate that WB with PTA 
enrichment of cerebrum samples is a sensitive, specific, and practi-
cal method for analyzing the samples from late stage scrapie or 
Figure 3. Demonstration of typical PrPSc band pattern by serial dilutions of 
a phosphotungstic acid (PTA) enriched scrapie positive sample. Lane 1, 
original (100%) PTA enriched sample; 2 to 4, PTA enriched, serially (50%, 
25%, and 12.5%, respectively) diluted from the sample of lane 1. MW mark-
ers (arrows) 30 kDa and 20 kDa shown on left.
Figure 4. Detection of chronic wasting disease (CWD) PrPSc by Western 
blot (WB) of crude homogenates and phosphotungstic acid (PTA) precipi-
tated samples from negative control elk sample 25 (lanes 2 to 4), positive 
sample 4 (lanes 5 to 7), and positive sample 7 (lanes 8 to 10), analyzed 
after proteinase K (PK) digestion and PTA precipitation (lanes 2, 5, 8), as 
crude homogenates (lanes 3, 6, 9) or without PK digestion or PTA precipi-
tation (lanes 4, 7, 10). MW markers (arrows) 30 kDa and 20 kDa shown 
on left.
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CWD. This method would be valuable for autolyzed tissues or for 
confirmation of IHC results. Paired samples from lymphoid tissue 
and from the medulla at the level of the obex will be needed to 
determine the diagnostic sensitivity of the WB test for preclinical 
TSE in sheep, deer, and elk.
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